The morbidity due to schistosomiasis has been shown to be greater than was previously
thought. The reduction in morbidity of schistosomiasis by control programmes has been …

Approximately 80% of the 200 million people infected with schistosomiasis inhabit sub-
Saharan Africa, and the annual mortality is estimated to be 280,000. Praziquantel is the drug …

Schistosomiasis is the major public health problem in rural Egypt, with almost six million
Egyptians infected as at mid-1996. In 1983, the prevalence of schistosomiasis in rural Egypt …

The effort to control schistosomiasis appeared to be more intense a few years ago in
Nigeria. Schistosomiasis affects all age groups, however, school children are at the highest …

This paper reviews the impact of schistosomiasis on public health and weighs the results
against experiences with new control methods in subsaharan Africa. Good short-term results …

Although a disease of great antiquity, scientific studies of schistosomiasis began only 150
years ago. The complete life-cycle was not described until just before the First World War …

Schistosomiasis is a common neglected tropical disease of impoverished people and
livestock in many developing countries in tropical Africa, the Middle East, Asia, and Latin …

This paper reviews 10 years' experience with schistosomiasis control in different endemic
settings in Africa, Asia and the Americas. Research projects, pilot programs and long-term …

Schistosomiasis, a parasitic disease caused by trematode worms, affects approximately 260
million people worldwide; more than 90% of cases occur in the WHO African Region (WHO …

It presents information on global status of schistosomiasis and its control, morbidity and its
regression after control, chemotherapy, control tools and activities, evidence building …